{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:50:37Z","timestamp":1791521437380,"version":"4.3.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Claims of priority statement<\/jats:title>\n                    <jats:p>After conducting a literature review in July 2026 through PubMed, Google Scholar, Cochrane, and Web of Science databases using the keywords (Bleb needling; Encapsulated bleb; Mitomycin C; PAUL Glaucoma Implant; Primary congenital glaucoma), we did not find any prior similar reports. Therefore, to the best of our knowledge, this is the first report of successful needling of the PAUL Glaucoma Implant in a child with primary congenital glaucoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To report the clinical outcomes of a minimally invasive, stepwise transconjunctival bleb needling with mitomycin C (MMC) to rescue a failing, encapsulated PAUL Glaucoma Implant (PGI) in a pediatric patient with refractory primary congenital glaucoma (PCG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case report of a 9-year-old female patient with a complex surgical history, including bilateral deep sclerectomies and PGIs, who presented with uncontrolled left intraocular pressure (IOP) of 27 mmHg despite maximal medical therapy. Baseline B-scan ultrasonography and clinical examination confirmed a +1 encapsulated, loculated fluid collection surrounding the left implant plate. The patient underwent an uneventful, stepwise transconjunctival needle revision using a 27-gauge needle combined with a subconjunctival injection of a 0.3 mL mixture of 0.4 mg\/mL MMC and 2% lidocaine to mechanically disrupt the fibrous capsule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On postoperative day 1, the left IOP was 24 mmHg with a deep anterior chamber. At the 9-day follow-up, the left IOP dropped to 14\u201317 mmHg with the formation of a quiet, diffuse bleb. By 1.5 months postoperatively, excellent stabilization was achieved with a left IOP of 10 mmHg and best-corrected visual acuity maintained at 20\/40 (isolated optotypes reaching 20\/30). At the final follow-up (2 months and 11 days), the left IOP remained well-controlled at 13 mmHg. A secondary poor ocular surface with superficial punctate keratitis was successfully managed with aggressive topical lubrication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Transconjunctival bleb needling augmented with MMC is an effective, conservative alternative to full surgical revision or implant replacement for managing encapsulated, hypertensive drainage blebs following PGI surgery in pediatric patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2026.1952678","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:27:20Z","timestamp":1791520040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Successful needle revision of an encapsulated bleb following PAUL glaucoma Implant surgery in a pediatric patient"],"prefix":"10.3389","volume":"6","author":[{"given":"Abdulrahman","family":"Kaki","sequence":"first","affiliation":[{"name":"Glaucoma Division, King Khaled Eye Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumanah","family":"Qedair","sequence":"additional","affiliation":[{"name":"Riyadh Second Health Cluster, Ministry of Health","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Alzendi","sequence":"additional","affiliation":[{"name":"Glaucoma Division, King Khaled Eye Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Schargel","sequence":"additional","affiliation":[{"name":"Glaucoma Division, King Khaled Eye Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"B1","unstructured":"Primary congenital glaucoma\n          \n          \n            \n              Kaur\n              K\n            \n            \n              Zeppieri\n              M\n            \n            \n              Gurnani\n              B\n            \n          \n          Statpearls\n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-01957-0","article-title":"Primary congenital glaucoma surgery: outcomes and visual function","volume":"41","author":"Gusson","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/BIOENGINEERING12080859","article-title":"Mitomycin C in Ahmed glaucoma valve implant affects surgical outcomes","volume":"12","author":"Lin","year":"2025","journal-title":"Bioengineering"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/J.OPHTHA.2016.06.035","article-title":"The Ahmed versus Baerveldt study: Five-year treatment outcomes","volume":"123","author":"Christakis","year":"2016","journal-title":"Ophthalmology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/J.OPHTHA.2014.08.043","article-title":"Five-year treatment outcomes in the Ahmed Baerveldt comparison study","volume":"122","author":"Budenz","year":"2015","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/IIO.0000000000000499","article-title":"Glaucoma drainage device implantation, outcomes, and complications","volume":"63","author":"Oatts","year":"2023","journal-title":"Int Ophthalmol Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/S00417-025-06861-2","article-title":"The Paul glaucoma implant: a systematic review of safety, efficacy, and emerging applications","volume":"263","author":"Carl\u00e0","year":"2025","journal-title":"Graefe\u2019s Arch For Clin Exp Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.OGLA.2020.05.001","article-title":"Treatment outcomes using the PAUL glaucoma implant to control intraocular pressure in eyes with refractory glaucoma","volume":"3","author":"Koh","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/DESIGNS9060145","article-title":"Glaucoma drainage devices and minimally invasive glaucoma surgery\u2014evolution of designs and materials","volume":"9","author":"Tunga","year":"2025","journal-title":"Designs"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/BCR-2021-244553","article-title":"Management of a recurrent encapsulated bleb with a cost-effective non-valved glaucoma drainage device","volume":"15","author":"Puthuran","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOC.2020.100795","article-title":"Successful needling of previous failed deep-sclerectomy in a child with primary congenital glaucoma","volume":"19","author":"Dibaji","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.71598","article-title":"Mitomycin-C needle bleb revision in congenital glaucoma","volume":"17","author":"Elsayed","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/S10384-024-01076-0","article-title":"Efficacy and safety of the Paul glaucoma implant in the treatment of refractory primary congenital glaucoma","volume":"68","author":"Karapapak","year":"2024","journal-title":"Jpn J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41433-026-04748-y","article-title":"Long-term outcomes of the Paul glaucoma implant in a paediatric population: A retrospective cohort study","volume":"40","author":"Fang","year":"2026","journal-title":"Eye"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/BIOENGINEERING11050446","article-title":"Wound modulations in glaucoma surgery: A systematic review","volume":"11","author":"Dave","year":"2024","journal-title":"Bioengineering"},{"key":"B16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/WOUND.2013.0436","article-title":"Integrins in wound healing","volume":"3","author":"Koivisto","year":"2014","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30155-9","article-title":"Needling versus medical treatment in encapsulated blebs. A randomized, prospective study","volume":"104","author":"Costa","year":"1997","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/J.JAAPOS.2009.05.006","article-title":"Cyclophotocoagulation versus sequential tube shunt as a secondary intervention following primary tube shunt failure in pediatric glaucoma","volume":"13","author":"Sood","year":"2009","journal-title":"J AAPOS: Off Publ Am Assoc For Pediatr Ophthalmol Strabismus \/ Am Assoc For Pediatr Ophthalmol Strabismus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001052","article-title":"Needling with 5-Fluorouracil (5-FU) after XEN gel stent implantation: 6-month outcomes","volume":"27","author":"Arnljots","year":"2018","journal-title":"J Glaucoma"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1952678\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:27:21Z","timestamp":1791520041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1952678\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":19,"alternative-id":["10.3389\/fopht.2026.1952678"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1952678","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1952678"}}